Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes
Get Live Data
27.00    0.20 (0.75%)
Bid:
25.60
Ask:
26.70
Spread: 1.10 (4.297%)
Market Cap: £116.17m
EKF Live PriceLast checked at - London Stock Exchange

Intraday Ekf Diagnostics Share Chart

AGM Statement

15 May 2006 10:26

Immediate Release: 15 May 2006 International Brand Licensing plc ("IBL" or the "Company") AGM Statement At today's AGM, Chairman Adam Reynolds commented:"In my statement of 19th April 2006, I was pleased to report a substantialturnaround in the Company's fortunes by producing a full year profit for thefirst time in the Company's history.I am now delighted to announce to you that the current year has startedextremely well with the first four month's sales being around 25% higher thanthe corresponding period last year, which in itself was a record year. Inaddition, the Board is continuing to drive down fixed costs and is activelylooking at ways of increasing its gross margins through both manufacturing anddistribution efficiencies.It is both reassuring and rewarding that sales of the official England Admiralreplica kit are still outperforming all our expectations and that the Companyis further benefiting from its focus on cost savings since the Board wasrestructured last year.Last week, the Company announced the sale of its Admiral trademarks for theGreece and Cyprus territories for a cash consideration of ‚£775,000, reflectingthe increasing value of the Admiral brand globally. Whilst expanding thegeographical reach of the Admiral brand remains at the core of the Company'sstrategy, our over-riding aim is to maximise shareholder value which we firmlybelieve this transaction achieved.We are currently in discussion with several potential partners regarding thesigning of new long term license agreements in regions where we are currentlynot represented. We are confident that the number of territories in which theAdmiral brand is distributed, currently 22, can be substantially increased inthe medium to long term, ensuring continued strong growth in the business goingforward.Your Board is delighted with the progress the Company has made during the yearto date and we remain confident that we will continue to improve shareholdervalue throughout the year ahead."For Further information:Adam Reynolds/Paul FoulgerInternational Brand Licensing020 7823 1733ENDINTERNATIONAL BRAND LICENSING PLC
Date   Source Headline
2nd Jun 20147:00 amRNSMajor step towards detecting cancer in blood
2nd Jun 20147:00 amRNSDirectorate Change
27th May 20143:59 pmRNSHolding(s) in Company
23rd May 201411:30 amRNSHolding(s) in Company
21st May 20144:40 pmRNSSecond Price Monitoring Extn
21st May 20144:35 pmRNSPrice Monitoring Extension
20th May 20144:36 pmRNSResult of AGM
20th May 20147:01 amRNSAGM Statement
20th May 20147:00 amRNSSelah to provide Women's Health testing services
19th May 20143:13 pmRNSHolding(s) in Company - Replacement
16th May 20144:35 pmRNSHolding(s) in Company
15th May 20147:00 amRNSDirector/PDMR Shareholding
8th May 20141:10 pmRNSDirector/PDMR Shareholding
7th May 20147:00 amRNSSelah update
30th Apr 20147:01 amRNSHolding(s) in Company
23rd Apr 20144:46 pmRNSHolding(s) in Company
23rd Apr 20143:33 pmRNSHolding(s) in Company
17th Apr 20141:13 pmRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSInvestor Teach-In
11th Apr 201411:33 amRNSResults of General Meeting and Total Voting Rights
10th Apr 20149:33 amRNSResult of Offer
31st Mar 20144:46 pmRNSDirector Resignation
31st Mar 201410:01 amRNSHolding(s) in Company
26th Mar 20144:18 pmRNSHolding(s) in Company
24th Mar 20147:00 amRNSHolding(s) in Company Replacement
20th Mar 201411:26 amRNSResult of the Placing
20th Mar 20147:00 amRNSProposed Acquisitions, Placing & Offer
12th Mar 20147:00 amRNSAcquisition of Separation Technology, Inc.
4th Mar 201411:16 amRNSTransfer of production
26th Feb 20147:00 amRNSFinal Results
18th Feb 20147:00 amRNSQuo-Lab registration in Mexico
17th Feb 20147:00 amRNSNotice of Results
28th Jan 201412:21 pmRNSAdditional Listing
27th Jan 20147:00 amRNSYear end trading update
24th Jan 20147:00 amRNSHolding(s) in Company
20th Jan 20147:00 amRNSPointMan enriches low-level mutations from blood
19th Nov 20137:00 amRNSAcute Kidney Injury marker development
4th Nov 20137:00 amRNSNew PointManT DNA enrichment products launched
30th Oct 20133:10 pmRNSHolding(s) in Company
8th Oct 20138:25 amRNSHolding(s) in Company
3rd Oct 20139:03 amRNSChange of Registered Office
25th Sep 201311:34 amRNSHolding(s) in Company
19th Sep 20137:28 amRNSInvestor Results Briefing
16th Sep 20137:00 amRNSInterim Results
14th Aug 20137:00 amRNSInvestor Teach-In
1st Aug 20137:00 amRNSTrading update
25th Jul 20137:00 amRNSInvestor Teach-In
23rd Jul 20137:00 amRNSSenior management update
4th Jul 201312:09 pmRNSHolding(s) in Company
26th Jun 20135:43 pmRNSAnalyst & Investor Teach-In

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.